Expression of Insulin-Like Growth Factor Binding Protein-5 (IGFBP5) Reverses Cisplatin-Resistance in Esophageal Carcinoma

Cisplatin (CDDP) is one of the front-line chemotherapeutic drugs used in the treatment of esophageal squamous cell carcinoma (ESCC). Occurrence of resistance to CDDP has become one of the main challenges in cancer therapy. In this study, the gene expression profile of CDDP-resistant ESCC cells was i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Dessy, Zhou, Yuanyuan, Chui, Chung Hin, Lam, Kim Hung, Law, Simon, Chan, Albert Sun-chi, Li, Xingshu, Lam, Alfred King-yin, Tang, Johnny Cheuk On
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210716/
https://www.ncbi.nlm.nih.gov/pubmed/30241323
http://dx.doi.org/10.3390/cells7100143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210716/
https://www.ncbi.nlm.nih.gov/pubmed/30241323
http://dx.doi.org/10.3390/cells7100143

Ejemplares similares